Approved Marketing Authorisations (MA) of Substipharm in Europe aggregated by PharmaCompass

2-Hydroxymetronidazole

Amorolfine

Anas Barbariae Hepatis Cordis Extract

Anastrozole

Atenolol; Nifedipine

Bisacodyl

Clobetasol

Clobetasol 17-Butyrate

Clobetasol Propionate

Cloxacillin

Dexpanthenol

Duloxetine Hydrochloride

Ebastine

Etifoxine

FENTICONAZOLE NITRATE

Fenticonazole

Fosfomycin Trometamol

Glycerol; Petrolatum; Paraffin

Hydroxyzine Hydrochloride

Ivabradine Hydrochloride

Ivermectin

Ketoconazole

Levocetirizine Dihydrochloride

Metronidazole

Metronidazole Benzoate

Metronidazole HCl

Midodrine

Mitomycin

Mometasone

Mometasone Furoate Monohydrate

Mupirocin

Olmesartan Medoxomil

Olmesartan Medoxomil; Hydrochlorothiazide

Rupatadine

Solifenacin Succinate

Triamcinolone Acetonide

Triamcinolone Acetonide Acetate

Urapidil

Ursodeoxycholic Acid

Vitamin D3

Zolpidem

Zolpidem Hemitartrate

Zolpidem Tartrate

Autolysate Pellet

Capsule

Cream

Film Coated Tablet

Gastro Resistant Capsule

Gastro Resistant Tablet

Granules for Oral Solution

Nail Lacquer

Nasal Spray

Ointment

Oral Solution

Orodispersible Tablet

Powder for Solution for Injection or Infusion

Scored Film Coated Tablet

Soft Gelatin Capsule

Tablet

0.05%

1

10

100000IU

10MG

10mg

15; 2; 8

2

2.5

20

200

20MG; 12.5MG

20MG; 25MG

20mg

250mg

25mg

3

30

40

40MG; 12.5MG

40MG; 25MG

5

5%

50

500

500mg

50; 20

50mcg

55mcg

55mcg/16ml

5MG

5mg

60

600mg

60MG

7.5

90MG

FRANCE

Delursan

Dermoval

Flagyl

Loceryl

Lomexin

Nasacort

Nasonex

Stilnox

Blank